Olema Pharmaceuticals, Inc.
OLMA
$10.63
$0.121.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -44.34% | -74.70% | -37.22% | -22.17% | -44.11% |
| Total Depreciation and Amortization | -22.73% | -7.03% | 61.21% | -54.74% | 40.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 266.76% | 257.88% | -31.68% | -17.48% | -14.48% |
| Change in Net Operating Assets | -50.30% | 86.53% | 90.12% | 25.12% | 1,066.15% |
| Cash from Operations | -53.59% | -4.57% | -45.82% | -27.80% | -8.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.95% | 110.05% | -41.74% | -62.38% | 802.67% |
| Cash from Investing | 19.30% | 110.05% | -41.74% | -62.38% | 801.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 348.78% | 21,244.49% | -9.62% | -55.43% | -93.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 103.65% | -1,771.43% | -101.75% | -- | -- |
| Cash from Financing | 143.96% | 20,487.39% | -12.59% | -55.43% | -116.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -315.38% | 104.78% | -87.41% | -190.61% | 110.89% |